| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1988PNAS...85.2568H |
| P356 | DOI | 10.1073/PNAS.85.8.2568 |
| P932 | PMC publication ID | 280038 |
| P698 | PubMed publication ID | 3357883 |
| P5875 | ResearchGate publication ID | 19798200 |
| P50 | author | R. John Collier | Q2123854 |
| P2093 | author name string | J J Mekalanos | |
| S B Calderwood | |||
| C J Hovde | |||
| P2860 | cites work | Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities | Q24646436 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors | Q26778475 | ||
| 2 New M13 vectors for cloning | Q27861042 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes | Q34163395 | ||
| Vero response to a cytotoxin of Escherichia coli | Q34177128 | ||
| Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli | Q34633814 | ||
| Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. | Q36265701 | ||
| Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus | Q36269210 | ||
| Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity | Q36270771 | ||
| Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock. | Q36342126 | ||
| Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. | Q36349737 | ||
| Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups | Q37040666 | ||
| Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli | Q37112219 | ||
| Tinkering with enzymes: what are we learning? | Q39656946 | ||
| Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B. | Q40184317 | ||
| Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes | Q40244862 | ||
| Dysentery in pigs associated with cystic enlargement of submucosal glands in the large intestine | Q40797842 | ||
| Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli | Q42657348 | ||
| Ribosome-inhibiting proteins, retroviral reverse transcriptases, and RNase H share common structural elements | Q45244947 | ||
| Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein | Q48350458 | ||
| Subunit structure of Shigella cytotoxin. | Q50938170 | ||
| Affinity labeling of the active sites in the sucrase-isomaltase complex from small intestine. | Q54263161 | ||
| The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. | Q54408348 | ||
| Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity. | Q54793009 | ||
| The three-dimensional structure of ricin at 2.8 A | Q68962681 | ||
| Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli | Q71454940 | ||
| The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit | Q71855282 | ||
| Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin | Q72548803 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2568-72 | |
| P577 | publication date | 1988-04-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | |
| P478 | volume | 85 |
| Q46528787 | A Cell-Based Fluorescent Assay to Detect the Activity of AB Toxins that Inhibit Protein Synthesis |
| Q35104239 | A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit |
| Q36957798 | An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine |
| Q33529309 | An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo |
| Q33719498 | Analysis of Escherichia coli O157:H7 survival in ovine or bovine manure and manure slurry. |
| Q36104552 | Analysis of the complexity of gene regulation by fur in Vibrio cholerae |
| Q34007607 | Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation |
| Q34531637 | Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells |
| Q35380050 | Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane |
| Q33267808 | Characterisation of saporin genes: in vitro expression and ribosome inactivation |
| Q36543943 | Characterization of Escherichia coli O157:H7 and other Shiga toxin-producing E. coli serotypes isolated from sheep. |
| Q33991926 | Characterization of the major control region of Vibrio cholerae bacteriophage K139: immunity, exclusion, and integration. |
| Q34166278 | Charged and hydrophobic surfaces on the a chain of shiga-like toxin 1 recognize the C-terminal domain of ribosomal stalk proteins |
| Q68090249 | Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279 |
| Q36215407 | Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine |
| Q35548775 | Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains |
| Q34500172 | Comparison of Xenorhabdus bovienii bacterial strain genomes reveals diversity in symbiotic functions. |
| Q37424949 | Conserved Arginines at the P-Protein Stalk Binding Site and the Active Site Are Critical for Ribosome Interactions of Shiga Toxins but Do Not Contribute to Differences in the Affinity of the A1 Subunits for the Ribosome |
| Q33754052 | Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. |
| Q54645159 | Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins. |
| Q52668818 | Decreased STEC shedding by cattle following passive and active vaccination based on recombinant Escherichia coli Shiga toxoids. |
| Q34003042 | Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae |
| Q33767533 | Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity |
| Q41770295 | Diverse phage-encoded toxins in a protective insect endosymbiont |
| Q26858938 | Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2? |
| Q82754354 | Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection |
| Q36527889 | Escherichia coli O157:H7 in microbial flora of sheep |
| Q39480986 | Establishment of recombinant hybrid-IgG/IgA immunoglobulin specific for Shiga toxin. |
| Q39454929 | Evaluation of biological safety in vitro and immunogenicity in vivo of recombinant Escherichia coli Shiga toxoids as candidate vaccines in cattle |
| Q60311719 | Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway |
| Q24672377 | Exploring steric constraints on protein mutations using MAGE/PROBE |
| Q33991131 | Functional analysis of a rickettsial OmpA homology domain of Shigella flexneri icsA. |
| Q48220960 | Genetic and Immunological Analysis of a Novel Variant of Shiga Toxin 1 from Bovine Escherichia coli Strains and Development of Bead‐ELISA to Detect the Variant Toxin |
| Q35423953 | Heterologous antigen expression in Vibrio cholerae vector strains |
| Q34663367 | Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae |
| Q35620166 | Investigation of ribosome binding by the Shiga toxin A1 subunit, using competition and site-directed mutagenesis |
| Q54323381 | Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production. |
| Q36973773 | Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II |
| Q36103964 | Minimum domain of the Shiga toxin A subunit required for enzymatic activity |
| Q35626584 | Molecular cloning of an apoptosis-inducing protein, pierisin, from cabbage butterfly: possible involvement of ADP-ribosylation in its activity |
| Q36165342 | Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits |
| Q33897718 | NADP and NAD utilization in Haemophilus influenzae |
| Q33950279 | NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in Haemophilus influenzae |
| Q39896145 | Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity |
| Q35552261 | Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q33369261 | Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome |
| Q35060348 | Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1. |
| Q33377371 | Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B |
| Q35551627 | Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain |
| Q24567536 | Ribosome inactivation by ricin A chain: a sensitive method to assess the activity of wild-type and mutant polypeptides |
| Q40647546 | Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes |
| Q40651036 | Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes |
| Q40646196 | Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae |
| Q27021676 | Shiga Toxin (Stx) Classification, Structure, and Function |
| Q26752966 | Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications |
| Q34715023 | Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells |
| Q34140727 | Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility |
| Q38776306 | Strategies for the development of vaccines for typhoid fever, shigellosis, and cholera |
| Q92153341 | Structural and Functional Characterization of Stx2k, a New Subtype of Shiga Toxin 2 |
| Q34451464 | Synthesis of an Aminooxy Derivative of the Trisaccharide Globotriose Gb3 |
| Q27730899 | The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin |
| Q54648744 | The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain. |
| Q34288923 | The use of Shiga-like toxin 1 in cancer therapy |
| Q33719947 | Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli |
| Q36191893 | Transcriptional regulation by iron of a Vibrio cholerae virulence gene and homology of the gene to the Escherichia coli fur system |
| Q33376138 | Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome |
| Q39927930 | Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement |
| Q35461166 | Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine |
| Q40782927 | Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). |
| Q35968495 | Vibrio cholerae fur mutations associated with loss of repressor activity: implications for the structural-functional relationships of fur. |
Search more.